Skip to main navigation Skip to search Skip to main content

Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1

  • Jeroen Roose
  • , Gerwin Huls
  • , Moniek Van Beest
  • , Petra Moerer
  • , Karin Van Der Horn
  • , Roel Goldschmeding
  • , Ton Logtenberg
  • , Hans Clevers

Research output: Contribution to journalArticlepeer-review

415 Citations (Scopus)

Abstract

Mutations in APC or β-catenin inappropriately activate the transcription factor Tcf4, thereby transforming intestinal epithelial cells. Here it is shown that one of the target genes of Tcf4 in epithelial cells is Tcf1. The most abundant Tcf1 isoforms lack a β-catenin interaction domain. Tcf1(-/-) mice develop adenomas in the gut and mammary glands. Introduction of a mutant APC allele into these mice substantially increases the number of these adenomas. Tcf1 may act as a feedback repressor of β-catenin-Tcf4 target genes and thus may cooperate with APC to suppress malignant transformation of epithelial cells.

Original languageEnglish
Pages (from-to)1923-1926
Number of pages4
JournalScience
Volume285
Issue number5435
DOIs
Publication statusPublished - 17 Sept 1999
Externally publishedYes

Fingerprint

Dive into the research topics of 'Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1'. Together they form a unique fingerprint.

Cite this